THE ROLE OF IMMUNOTHERAPY IN CANCER TREATMENT: CHECKPOINT INHIBITORS, CAR-T CELLS, AND VACCINESArun, Jagdish KumarSingh, Ashok KumarE. S., ShashidharPatel, Geetika M.Verma, YogitaSapcota, SamirGeorgian Medical News
Elizabeth Loggers, MD, PhD, medical oncologist, Seattle Cancer Care Alliance, discusses the role that she expects immunotherapy will play in the future treatment landscape of sarcoma. Recent Videos The Real-World Challenges of Cell and Gene Therapy in Oncology ...
ImmunotherapyImmune-checkpoint inhibitorsCancer vaccinesPD-1PD-L1CTLA-4Despite decades of research, prognosis for SCLC patients remains poor, and treatment options limited. SCLC is an immunogenic tumor with high somatic mutation rates due to tobacco exposure resulting in potential neo-antigens, the ...
Fractionated locoregional low-dose radioimmunotherapy improves survival in a mouse model of diffuse-type gastric cancer using a 213Bi-conjugated monoclonal... Treatment OutcomeImmunotherapyRadioimmunotherapyPurpose: Locoregional radioimmunotherapy of i.p. tumor cell dissemination of diffuse-type gastric cancer ...
Traditional Treatment Approaches and Role of Immunotherapy in Lung Malignancy and Mesothelioma. Simple Summary: Pleural Mesothelioma is a rare and highly aggressive illness with a grim prognosis. Surgical procedures are crucial in achieving accurate d... MT Tamanna,C Egbune - 《Cancer Treatment & Res...
RoleofImmunotherapyin Triple-NegativeBreastCancer TanyaE.Keenan,MD,MPH, 1,2 andSaraM.Tolaney,MD,MPH 1,2 ABSTRACT Immunecheckpointinhibitors(ICIs)haveledtodurableclinicalre- missionsinmanymetastaticcancers.However,thesingle-agenteffi- cacyofICIsinbreastcancerislow,includingintriple-negativebreast ...
In recent years, thanks to new advances in tumor immunology, immunotherapy became a part of intensive research as a novel strategy in cancer treatment. Sipuleucel T is the first and only medicinal product approved by the regulatory agencies in the USA and Europe for the treatment of asymptomati...
Immunotherapy has transformed treatment for patients with stage 4 metastatic esophageal and gastric cancers. In patients with these malignancies, immunotherapy has been shown to prolong survival when patients' tumors exhibit a high expression of an immun
Cancer is a malignant tumor that seriously threatens human life and health. At present, the main treatment methods include surgical resection, chemotherapy, radiotherapy, and immunotherapy. However, the mechanism of tumor occurrence and development is complex, and it produces resistance to some tradition...
immunotherapy [6]. NK cells can detect tumors without the need for antigen-specific receptors, as they recognize patterns specific to cancer cells. This allows them to recognize a broad range of changes present on malignant cells that are not present in the body’s normal cells and to respond...